9-ING-41 in Pediatric Patients With Refractory Malignancies.

Clinical trial NCT04239092 · TERMINATED

Trial details

NCT number: NCT04239092
Sponsor: Actuate Therapeutics Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory Cancer Refractory Neoplasm Cancer Pediatric Refractory Tumor Pediatric Cancer Pediatric Brain Tumor Neuroblastoma Neuroblastoma Recurrent Pediatric Lymphoma Pediatric Meningioma Diffuse Intrinsic Pontine Glioma

Start date: 2020-06-05
Primary completion: 2025-07-07
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.